Interleukin-35 Expression in Non-Small Cell Lung Cancer is Associated with Tumor Progression
Conclusion: Our results showed that IL-35 plays an inhibitory role in NSCLC development and function as a novel prognostic indicator and a potential therapeutic target.Cell Physiol Biochem 2018;51:1839 –1851
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Chemotherapy | Cytology | Lung Cancer | Non-Small Cell Lung Cancer | Physiology | Study